Pharmazeutisches Rohmaterial CAS 474-25-9 Chenodeoxycholsäure-Pulver

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Weißes Pulver
• Purity: >99%
• Aussehen: Weißes Pulver
• Haltbarkeit: 2 Jahre
• Lagerung: An einem kühlen und trockenen Ort aufbewahren
• Lieferung: express 5-7 Tage Ankunft
• Testmethode: hplc
• Test: 99 %
• Versandbereich: Weltweit/alle Länder
• cas: 474-25-9
• Service: Guter Service
• Liefermethode: fedex/dhl/Sonderlinie
• Produktname: Chenodeoxycholsäure
• Transportpaket: Foil Bag
• Spezifikation: 99 %
• Warenzeichen: Xi′an Frazer Biotech Co., Ltd.
• Herkunft: China
• Produktionskapazität: 200kg Per Month

Produktbeschreibung

Pharmaceutical Raw Material CAS 474-25-9 Chenodeoxycholic Acid Powder

Specification of Analysis

Product Name	Chenodeoxycholic Acid Powder
Purity	99%
MF	C24H40O4
Appearance	White Powder
Test Method	HPLC

Chenodeoxycholic acid is the first agent to be introduced into the US market for the treatment of radiolucent gallstones. Large scale clinical trials have demonstrated the safety and efficacy of this agent. Chenodeoxycholic acid reduces the biliary concentration of cholesterol relative to that of bile acids and phospholipid, reducing the saturation and thus the lithogenicity of the bile. Success rates in dissolving gallstones are in the range of 50-70% within 4-24 months of treatment. Continuation of the drug after stone dissolution may be required to prevent reoccurrence.

Function

Chenodeoxycholic acid is a bile acid synthesized in the liver from cholesterol. henodeoxycholic acid has been used in a study to assess its effects as a long-term replacement therapy for cerebrotendinous xanthomatosis (CTX). It has also been used in a study to investigate its effects on the small-intestinal absorption of bile acids in patients with ileostomies.